eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2011
vol. 7
 
Share:
Share:
more
 
 
abstract:

Association on cardiovascular interventions of PCS
Current status of drug-eluting stents and drug-eluting balloons in patients with stable coronary artery disease: An expert consensus document of the Association for Percutaneous Cardiovascular Interventions and Polish Cardiac Society

Adam Witkowski, Maksymilian P. Opolski, Dariusz Dudek, Maciej Lesiak, Jacek Legutko, Wojciech Wojakowski, Andrzej Ochała, Paweł Maciejewski, Tomasz Deptuch, Aleksander Araszkiewicz, Dariusz Ciećwierz

Post Kardiol Interw 2011; 7, 1 (23): 20-55
Online publish date: 2011/04/08
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Despite a dramatic reduction in restenosis and target vessel revascularization rates by drug-eluting stents (DES), conflicting concerns have been raised over the risk of late DES thrombosis when compared to bare-metal stents. Certainly, the heterogeneity of DES results from the introduction of a great variety of new DES types with diverse efficacy and safety parameters. Furthermore, there is a steady increase in DES availability without parallel and robust data from randomized clinical trials. Thus, the postulated class effect of DES should be regarded as non-obligatory. This article is based on 110 randomized DES trials performed on 72 305 patients. Current status of DES and guidelines for DES implantation in various clinical scenarios are discussed.
keywords:

drug-eluting stents, drug-eluting balloons, randomized clinical trials

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe